drugset / Trial / NCT05106400

Clinical Adhesion Study Between ZTlido 1.8% and Three Over-the-counter External Analgesic Lidocaine-containing Patches

NCT05106400

Phase 1 Completed 24 enrolled Scilex Pharmaceuticals, Inc.
RandomizedCrossoverOpen-labelOther

Summary

The study is designed to evaluate and compare the clinical adhesion performance of the ZTlido (Lidocaine Topical System) 1.8% of Scilex Pharmaceuticals Inc. (Reference) versus Salonpas (Lidocaine Patch 4%), Aspercreme (Lidocaine Patch 4%) and IcyHot (Lidocaine 4% + Menthol 1% Patch), on the Mid to upper back while being worn for 12 hours in healthy adult human subjects.

Timeline

Start
2021-07-01
Primary completion
2021-07-21
Completion
2021-07-21

Drugs

EvaluationDrugModalityDoseRoute
Subject Lidocaine Other / unclassified 1.8 % Topical
Subject Lidocaine Other / unclassified 4 % Topical
Subject Menthol Small molecule 1 % Topical

Indications

No indication recorded.